Late Breaking Abstract - Real-world effectiveness of sotrovimab for the early treatment of COVID-19 in the US
C. Reyes (San Francisco, United States), M. Cheng (San Francisco, United States), D. Gibbons (Brentford, United Kingdom), H. Birch (Brentford, United Kingdom), V. Patel (Brentford, United Kingdom), C. Bell (Research Triangle Park, United States), M. Drysdale (Brentford, United Kingdom), S. Satram (San Francisco, United States)
Source: International Congress 2022 – What's new in COVID
Session: What's new in COVID
Session type: Oral Presentation
Number: 3802
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Reyes (San Francisco, United States), M. Cheng (San Francisco, United States), D. Gibbons (Brentford, United Kingdom), H. Birch (Brentford, United Kingdom), V. Patel (Brentford, United Kingdom), C. Bell (Research Triangle Park, United States), M. Drysdale (Brentford, United Kingdom), S. Satram (San Francisco, United States). Late Breaking Abstract - Real-world effectiveness of sotrovimab for the early treatment of COVID-19 in the US. 3802
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|